1.Commons RR, C.C., Adenomas of the adrenal cortex. Arch Intern Med, 1948. 81: p. 37-41.

2.Hedeland H, �.G., H�kfelt B, On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand, 1968. 184: p. 211-214.

3.Kokko JP, B.T., Bermann MM, Adrenal adenoma and hypertension. Lancet, 1967. 1: p. 468-470.

4.Shamma AH, G.J., Sommers SC 1958 A study of the adrenal status in hypertension. J Chron Dis 8:587-595, A study of the adrenal status in hypertension. J Chron Dis, 1958. 8: p. 587-595.

5.Russi S, B.H., Small adenomas of the adrenal cortex in hypertension and diabetes. Arch Intern Med, 1945. 76: p. 284-291.

6.Chidiac, R.M. and D.C. Aron, Incidentalomas. A disease of modern technology. Endocrinol Metab Clin North Am, 1997. 26(1): p. 233-53.

7.Prinz, R.A., et al., Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Is operation required? Jama, 1982. 248(6): p. 701-4.

8.Allolio, B., Adrenal Incidentalomas. 1 ed. Adrenal Disorders, ed. C.G. Margioris AN. 2001, Totowa: Humana Press Inc. 249 - 261.

9.Lutz, A., et al., Adrenocortical function in patients with macrometastases of the adrenal gland. Eur J Endocrinol, 2000. 143(1): p. 91-7.

10.Reinhard C, S.W., Schubert B, Nodules and adenomas in the adrenal cortex: Incidence in post-mortem series and correlation with clinical data. Exp Clin Endocrinol, 1994. 102(Suppl 1): p. 192.

11.Dobbie, J.W., Adrenocortical nodular hyperplasia: the ageing adrenal. J Pathol, 1969. 99(1): p. 1-18.

12.Garz, G., M. Luning, and B. Melzer, [Computed tomographic incidental finding of a hormone-inactive adrenal cortex adenoma]. Radiol Diagn, 1985. 26(6): p. 761-6.

13.Glazer, H.S., et al., Nonfunctioning adrenal masses: incidental discovery on computed tomography. AJR Am J Roentgenol, 1982. 139(1): p. 81-5.

14.Kley HK, W.H., Jaresch S, Jungblut R, Schlaghecke R, Endokrin inaktive Nebennierentumoren., in Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen., S.H. Allolio B, Editor. 1990, Schattauer: New York. p. 189-197.

15.Stark S, P.M., Sachse R, Cidlinski K, Riel R, Hahn EG, D�rr HG, Buchfelder M, Hensen J, Endocrine inactive adrenocortical adenomas (ACA) are a condition of the eldery. Exp Clin Endocrinol, 1994. 102(Suppl 1): p. 193.

16.Kasperlik-Zeluska, A.A., et al., Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf), 1997. 46(1): p. 29-37.

17.Mantero, F., et al., A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab, 2000. 85(2): p. 637-44.

18.Russell, R.P., A.T. Masi, and E.D. Richter, Adrenal cortical adenomas and hypertension. A clinical pathologic analysis of 690 cases with matched controls and a review of the literature. Medicine (Baltimore), 1972. 51(3): p. 211-25.

19.Reincke M, A.B., Das Nebenniereninzidentalom: Die Kunst der Beschr�nkung in Diagnostik und Therapie. Dtsch. �rzteblatt, 1995. 92: p. 764-770.

20.Kloos, R.T., et al., Incidentally discovered adrenal masses. Endocr Rev, 1995. 16(4): p. 460-84.

21.Ross, N.S. and D.C. Aron, Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med, 1990. 323(20): p. 1401-5.

22.Latronico, A.C. and G.P. Chrousos, Extensive personal experience: adrenocortical tumors. J Clin Endocrinol Metab, 1997. 82(5): p. 1317-24.

23.NIH, Management of the Clinically Inapparent Adrenal Mass ("Incidentaloma"), in State-of-the-science Conference Statement. 2002, National Institute of Health.

24.Neville, A., The nodular adrenal. Invest Cell Pathol, 1978. 1: p. 99-111.

25.Reincke, M., et al., Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocr Res, 1996. 22(4): p. 757-61.

26.Grumbach, M.M., et al., Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med, 2003. 138(5): p. 424-9.

27.Bornstein, S.R., C.A. Stratakis, and G.P. Chrousos, Adrenocortical tumors: recent advances in basic concepts and clinical management. Ann Intern Med, 1999. 130(9): p. 759-71.

28.Allolio, B. and M. Fassnacht, Clinical review: Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab, 2006. 91(6): p. 2027-37.

29.Terzolo, M., et al., Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg, 1997. 132(8): p. 914-9.

30.Beuschlein, F., et al., Clonal composition of human adrenocortical neoplasms. Cancer Res, 1994. 54(18): p. 4927-32.

31.Gicquel, C., et al., Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clin Endocrinol (Oxf), 1994. 40(4): p. 465-77.

32.Reincke, M., et al., Molecular adrenocortical tumourigenesis. Eur J Clin Invest, 2000. 30 Suppl 3: p. 63-8.

33.Koch, C.A., K. Pacak, and G.P. Chrousos, The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. J Clin Endocrinol Metab, 2002. 87(12): p. 5367-84.

34.Jauresch-Hancke C, A.B., Metzler U, Bidlingmaier F, Winkelmann W, Adrenocortical carcinoma in a patient with untreated congenital adrenal hyperplasia. Acta Endocrinol 177 (Suppl), 1988(146-147).

35.Hammwi GJ, S.R., Kruger FA, Does adrenocortical hyperplasia result in adrenocortical carcinoma? N Engl J Med, 1957. 257: p. 1153-1155.

36.Jaresch, S., et al., Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J Clin Endocrinol Metab, 1992. 74(3): p. 685-9.

37.Jaresch S, S.R., Jungblut R, Kr�skemper HL, Kley HK, Stumme Nebennierentumoren bei Patienten mit adrenogenitalem Syndrom. Klin Wochschr, 1987. 65: p. 627-633.

38.Seppel, T. and R. Schlaghecke, Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas'). Clin Endocrinol (Oxf), 1994. 41(4): p. 445-51.

39.Terzolo, M., et al., Different patterns of steroid secretion in patients with adrenal incidentaloma. J Clin Endocrinol Metab, 1996. 81(2): p. 740-4.

40.New, M.I., et al., Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab, 1983. 57(2): p. 320-6.

41.Reincke, M., et al., Impairment of 11 beta-hydroxylase but not 21-hydroxylase in adrenal 'incidentalomas'. Eur J Endocrinol, 1997. 136(2): p. 196-200.

42.Schulze E, M.-G.C., Allolio B, Bornstein S, Reincke M, Steroid hormone levels and 21-hydroxylase matations in patients with adrenal incidentalomas. Abstr Endocrine Society Minneapolis, 1997.

43.Arnaldi, G., et al., Adrenal incidentaloma. Braz J Med Biol Res, 2000. 33(10): p. 1177-89.

44.Rossi, R., et al., Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab, 2000. 85(4): p. 1440-8.

45.Lacroix, A., et al., Abnormal adrenal and vascular responses to vasopressin mediated by a V1- vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. J Clin Endocrinol Metab, 1997. 82(8): p. 2414-22.

46.Lacroix, A., et al., Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome. N Engl J Med, 1992. 327(14): p. 974-80.

47.Reznik, Y., et al., Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med, 1992. 327(14): p. 981-6.

48.Haidan, A., et al., Human adrenocortical NCI-H295 cells express VIP receptors. Steroidogenic effect of vasoactive intestinal peptide (VIP). Peptides, 1998. 19(9): p. 1511-7.

49.Leinonen, P., et al., Testosterone-secreting virilizing adrenal adenoma with human chorionic gonadotrophin receptors and 21-hydroxylase deficiency. Clin Endocrinol (Oxf), 1991. 34(1): p. 31-5.

50.Mesiano, S., S.H. Mellon, and R.B. Jaffe, Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland. J Clin Endocrinol Metab, 1993. 76(4): p. 968-76.

51.Pillion, D.J., et al., Receptors for insulin and insulin-like growth factor-I in the human adrenal gland. Biochem Biophys Res Commun, 1989. 165(1): p. 204-11.

52.Penhoat, A., et al., Characterization of insulin-like growth factor I and insulin receptors on cultured bovine adrenal fasciculata cells. Role of these peptides on adrenal cell function. Endocrinology, 1988. 122(6): p. 2518-26.

53.Barzon, L., et al., Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab, 1999. 84(2): p. 520-6.

54.Libe, R., et al., Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol, 2002. 147(4): p. 489-94.

55.Hensen, J., et al., Endocrine activity of the "silent" adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone. Klin Wochenschr, 1990. 68(12): p. 608-14.

56.Osella, G., et al., Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J Clin Endocrinol Metab, 1994. 79(6): p. 1532-9.

57.Beyer, H.S. and R.P. Doe, Cortisol secretion by an incidentally discovered nonfunctional adrenal adenoma. J Clin Endocrinol Metab, 1986. 62(6): p. 1317-21.

58.Bogner, U., et al., Incidentally discovered ACTH-dependent adrenal adenoma presenting as 'pre-Cushing's syndrome'. Acta Endocrinol (Copenh), 1986. 111(1): p. 89-92.

59.Charbonnel, B., J.F. Chatal, and P. Ozanne, Does the corticoadrenal adenoma with "pre-Cushing's syndrome" exist? J Nucl Med, 1981. 22(12): p. 1059-61.

60.Reincke, M., et al., Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab, 1992. 75(3): p. 826-32.

61.Reincke, M., Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am, 2000. 29(1): p. 43-56.

62.Huiras, C.M., G.B. Pehling, and R.H. Caplan, Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas. Jama, 1989. 261(6): p. 894-8.

63.Torlontano, M., et al., Pre-Cushing's syndrome not recognized by conventional dexamethasone suppression-tests in an adrenal "incidentaloma" patient. J Endocrinol Invest, 1997. 20(8): p. 501-4.

64.Herrera, M.F., et al., Incidentally discovered adrenal tumors: an institutional perspective. Surgery, 1991. 110(6): p. 1014-21.

65.Siren, J.E., et al., Incidentalomas of the adrenal gland: 36 operated patients and review of literature. World J Surg, 1993. 17(5): p. 634-9.

66.Stein PP, B.H., A simplified diagnostic approach to pheochromocytoma. A review to the literature and report of institution�s experience. Medicine, 1990. 70: p. 46-66.

67.Lenders, J., et al., Biochemical Diagnosis of Pheochromocytoma. JAMA, 2002. 287(11): p. 1427-34.

68.Bravo, E.L., Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev, 1994. 15(3): p. 356-68.

69.Samaan, N.A., R.C. Hickey, and P.E. Shutts, Diagnosis, localization, and management of pheochromocytoma. Pitfalls and follow-up in 41 patients. Cancer, 1988. 62(11): p. 2451-60.

70.Gordon RD, S.A., Stowasser M, Tunny TJ, Storie WJ, Rutherford JC, How common is primary aldosteronism? Is it the most frequent cause of curable hypertension? Journal of Hypertension, 1993. 11(Suppl 5): p. S310-S311.

71.Gordon, R.D., et al., High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol, 1994. 21(4): p. 315-8.

72.Young, W.F., Jr., et al., Primary aldosteronism: diagnosis and treatment. Mayo Clin Proc, 1990. 65(1): p. 96-110.

73.Seiler, L., et al., Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. Eur J Endocrinol, 2004. 150(3): p. 329-37.

74.Hiramatsu, K., et al., A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med, 1981. 141(12): p. 1589-93.

75.Gordon, R.D., Primary aldosteronism. J Endocrinol Invest, 1995. 18(7): p. 495-511.

76.Phillips, J.L., et al., Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab, 2000. 85(12): p. 4526-33.

77.Flecchia, D., et al., Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clin Endocrinol (Oxf), 1995. 42(2): p. 129-34.

78.Orentreich, N., et al., Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab, 1984. 59(3): p. 551-5.

79.Korobkin, M., et al., Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology, 1996. 200(3): p. 743-7.

80.Lee, M.J., et al., Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology, 1991. 179(2): p. 415-8.

81.Boland, G.W., et al., Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol, 1998. 171(1): p. 201-4.

82.Rezneck RH, A.P., Imaging in endocrinology. The adrenal gland. Clin Endocrinol, 1994. 40: p. 561-576.

83.Heinz-Peer, G., et al., [Characterization of adrenal gland space-occupying lesions. Can diagnostic imaging replace biopsy?]. Radiologe, 1999. 39(7): p. 578-83.

84.Reinig, J.W., et al., Differentiation of adrenal masses with MR imaging: comparison of techniques. Radiology, 1994. 192(1): p. 41-6.

85.Doppman, J.L., et al., Differentiation of adrenal masses by magnetic resonance imaging. Surgery, 1987. 102(6): p. 1018-26.

86.Baker, M.E., et al., MR evaluation of adrenal masses at 1.5 T. AJR Am J Roentgenol, 1989. 153(2): p. 307-12.

87.Semelka, R.C., et al., Evaluation of adrenal masses with gadolinium enhancement and fat- suppressed MR imaging. J Magn Reson Imaging, 1993. 3(2): p. 337-43.

88.Krestin GP, F.G., Fischbach R, Neufang KF, Allolio B, Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhancement MR vs. CT. Comput Assist Tomogr, 1991. 15: p. 104-110.

89.Korobkin, M., et al., Characterization of adrenal masses with chemical shift and gadolinium- enhanced MR imaging. Radiology, 1995. 197(2): p. 411-8.

90.Tsushima, Y., H. Ishizaka, and M. Matsumoto, Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging. Radiology, 1993. 186(3): p. 705-9.

91.Bardet, S., et al., 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clin Endocrinol (Oxf), 1996. 44(5): p. 587-96.

92.Barzon, L., et al., Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab, 1998. 83(1): p. 55-62.

93.Copeland, P.M., The incidentally discovered adrenal mass. Ann Intern Med, 1983. 98(6): p. 940-5.

94.Nader, S., et al., Adrenal cortical carcinoma. A study of 77 cases. Cancer, 1983. 52(4): p. 707-11.

95.Arlt, W., et al., Suramin in adrenocortical cancer: limited efficacy and serious toxicity. Clin Endocrinol (Oxf), 1994. 41(3): p. 299-307.

96.Lewinsky, B.S., et al., The clinical and pathologic features of "non-hormonal" adrenocortical tumors. Report of twenty new cases and review of the literature. Cancer, 1974. 33(3): p. 778-90.

97.Saeger, W., et al., High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. Hum Pathol, 2003. 34(2): p. 180-6.

98.Saeger W, F.M., Beuschlein F, Prager G, Nies C, Lorenz K, B�rlehner E, Simon D, Niederle B, Allolio B, Reincke M, Ex-vivo biopsies of adrenal lesiona: Morphology of 231 cases. Exp Clin Endocrinol Diabetes, 2001. 109(Suppl 1): p. S19, v76.

99.Yankaskas, B.C., et al., Delayed complications from fine-needle biopsies of solid masses of the abdomen. Invest Radiol, 1986. 21(4): p. 325-8.

100.Habscheid, W., et al., [Puncture track metastasis after ultrasound-guided fine-needle puncture biopsy. A rare complication?]. Dtsch Med Wochenschr, 1990. 115(6): p. 212-5.

101.Silverman, S.G., et al., Predictive value of image-guided adrenal biopsy: analysis of results of 101 biopsies. Radiology, 1993. 187(3): p. 715-8.

102.McCorkell, S.J. and N.L. Niles, Fine-needle aspiration of catecholamine-producing adrenal masses: a possibly fatal mistake. AJR Am J Roentgenol, 1985. 145(1): p. 113-4.

103.Casola, G., et al., Unsuspected pheochromocytoma: risk of blood-pressure alterations during percutaneous adrenal biopsy. Radiology, 1986. 159(3): p. 733-5.

104.McLeod, M.K., et al., Sub-clinical Cushing's syndrome in patients with adrenal gland incidentalomas. Pitfalls in diagnosis and management. Am Surg, 1990. 56(7): p. 398-403.

105.Torlontano, M., et al., Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J Clin Endocrinol Metab, 1999. 84(7): p. 2381-5.

106.Osella, G., et al., Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas. J Clin Endocrinol Metab, 1997. 82(10): p. 3303-7.

107.Sartorio, A., et al., Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma. Eur J Endocrinol, 1998. 138(2): p. 146-52.

108.Chiodini, I., et al., Bone Loss Rate in Adrenal Incidentalomas: A longitudinal Study. J Clin Endocrinol Metabo, 2001. 86: p. 5337-5341.

109.Sellschopp, C., Aktuell Probleme der Nebennierenchirurgie, in Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen, S.H. Allolio B, Editor. 1990, Schattauer: New York. p. 145-151.

110.Fletcher, D.R., C.B. Beiles, and K.J. Hardy, Laparoscopic adrenalectomy. Aust N Z J Surg, 1994. 64(6): p. 427-30.

111.Mancini, F., et al., [Experiences with adrenalectomy in 1997. Apropos of 247 cases. A multicenter prospective study of the French-speaking Association of Endocrine Surgery]. Chirurgie, 1999. 124(4): p. 368-74.

112.Dralle, H., et al., Review: recent developments in adrenal surgery. Acta Chir Belg, 1994. 94(3): p. 137-40.

113.de Canniere, L., et al., Multicentric experience of the Belgian Group for Endoscopic Surgery (BGES) with endoscopic adrenalectomy. Surg Endosc, 1997. 11(11): p. 1065-7.